Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity.

Nature neuroscience (1999-11-26)
R R Ji, H Baba, G J Brenner, C J Woolf
RESUMEN

We investigated the involvement of extracellular signal-regulated protein kinases (ERK) within spinal neurons in producing pain hypersensitivity. Within a minute of an intense noxious peripheral or C-fiber electrical stimulus, many phosphoERK-positive neurons were observed, most predominantly in lamina I and IIo of the ipsilateral dorsal horn. This staining was intensity and NMDA receptor dependent. Low-intensity stimuli or A-fiber input had no effect. Inhibition of ERK phosphorylation by a MEK inhibitor reduced the second phase of formalin-induced pain behavior, a measure of spinal neuron sensitization. ERK signaling within the spinal cord is therefore involved in generating pain hypersensitivity. Because of its rapid activation, this effect probably involves regulation of neuronal excitability without changes in transcription.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Monoclonal Anti-Granulocyte Colony Stimulating Factor antibody produced in mouse, clone 3316.111, purified immunoglobulin, lyophilized powder
Sigma-Aldrich
Anti-Granulocyte Colony Stimulating Factor antibody produced in goat, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
Anti-Granulocyte Colony Stimulating Factor antibody produced in goat, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
Anti-Granulocyte Colony Stimulating Factor antibody produced in goat, IgG fraction of antiserum, lyophilized powder
Sigma-Aldrich
Monoclonal Anti-Granulocyte Colony Stimulating Factor antibody produced in rat, clone 67604, purified immunoglobulin, lyophilized powder

Redes sociales

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Investigación. Desarrollo. Producción.

Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos

© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.

Queda estrictamente prohibida la reproducción sin permiso de cualquiera de los materiales de la página web.